JP2005537480A5 - - Google Patents

Download PDF

Info

Publication number
JP2005537480A5
JP2005537480A5 JP2004532561A JP2004532561A JP2005537480A5 JP 2005537480 A5 JP2005537480 A5 JP 2005537480A5 JP 2004532561 A JP2004532561 A JP 2004532561A JP 2004532561 A JP2004532561 A JP 2004532561A JP 2005537480 A5 JP2005537480 A5 JP 2005537480A5
Authority
JP
Japan
Prior art keywords
toluene
product
bba
mol
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004532561A
Other languages
English (en)
Other versions
JP2005537480A (ja
Filing date
Publication date
Priority claimed from US10/233,071 external-priority patent/US20030082604A1/en
Application filed filed Critical
Publication of JP2005537480A publication Critical patent/JP2005537480A/ja
Publication of JP2005537480A5 publication Critical patent/JP2005537480A5/ja
Pending legal-status Critical Current

Links

Description

実施例3
オリゴヌクレオチド誘導体化光ポリマーの製造および評価
(a)4−ベンゾイルベンゾイルクロリド(BBA−C1)の製造
4−ベンゾイル安息香酸(BBA)1.0kg(4.42モル)を還流冷却器および吊り攪拌器(overhead stirrer)を備えた乾燥5リットルモルトンフラスコに加え、続けて塩化チオニル645ml(8.84モル)およびトルエン725mlを加えた。次いで、ジメチルホルムアミド3.5mlを加え、4時間加熱還流した。冷却後、溶媒を減圧下で除去し、残存塩化チオニルをトルエン3×500mlを用いて3度の蒸発により除去する。生成物をトルエン/ヘキサン(1/4)から再結晶化し、真空オーブン中での乾燥後、988g(収率91%)を得た。生成物の融点は、92〜94℃であった。80MHz(1HNMR(CDCl3))での核磁気共鳴(NMR)分析は、所望の生成物と一致した:芳香族プロトン7.20−8.25(m、9H)。化学シフト値はすべて、テトラメチルシラン内部標準から低磁場側のppmである。例えば実施例3(c)に記載される光活性可能なポリマーの合成に用いられるモノマーの製造における使用のため、または例えば実施例1(a)に記載されるヘテロ二官能性化合物のため、最終化合物を保存した。
JP2004532561A 2002-08-30 2003-04-01 高密度アレイ Pending JP2005537480A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/233,071 US20030082604A1 (en) 2000-09-27 2002-08-30 High density arrays
PCT/US2003/009795 WO2004020085A1 (en) 2002-08-30 2003-04-01 High density arrays

Publications (2)

Publication Number Publication Date
JP2005537480A JP2005537480A (ja) 2005-12-08
JP2005537480A5 true JP2005537480A5 (ja) 2006-06-01

Family

ID=31977141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004532561A Pending JP2005537480A (ja) 2002-08-30 2003-04-01 高密度アレイ

Country Status (6)

Country Link
US (1) US20030082604A1 (ja)
EP (1) EP1534420A1 (ja)
JP (1) JP2005537480A (ja)
AU (1) AU2003222130A1 (ja)
CA (1) CA2495922A1 (ja)
WO (1) WO2004020085A1 (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351575B2 (en) * 2000-11-08 2008-04-01 Surface Logix, Inc. Methods for processing biological materials using peelable and resealable devices
AT501110A1 (de) * 2003-09-16 2006-06-15 Upper Austrian Res Gmbh Arrays zur bindung von molekülen
EP2290073A3 (en) 2004-05-28 2011-08-31 Asuragen, Inc. Methods and compositions involving microRNA
US7524672B2 (en) * 2004-09-22 2009-04-28 Sandia Corporation Microfluidic microarray systems and methods thereof
US7592139B2 (en) 2004-09-24 2009-09-22 Sandia National Laboratories High temperature flow-through device for rapid solubilization and analysis
JP2006118920A (ja) * 2004-10-20 2006-05-11 Institute Of Physical & Chemical Research 相互作用観察方法
EP2302055B1 (en) 2004-11-12 2014-08-27 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
WO2006135782A2 (en) 2005-06-10 2006-12-21 Applera Corporation Method and system for multiplex genetic analysis
WO2008036776A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
DE102006059095A1 (de) * 2006-12-08 2008-06-12 Technische Universität Dresden Microarray, Verfahren und Kit zum Nachweis von Viren
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US8796184B2 (en) * 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
US20100056382A1 (en) * 2008-05-30 2010-03-04 Sussman Michael R Dna millichip
EP2542678B1 (en) 2010-03-04 2017-04-12 InteRNA Technologies B.V. A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS THERAPEUTIC USES IN CANCER ASSOCIATED WITH EMT
US8974651B2 (en) 2010-04-17 2015-03-10 C.C. Imex Illuminator for visualization of fluorophores
EP2591106A1 (en) 2010-07-06 2013-05-15 InteRNA Technologies B.V. Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
BR112013012265A2 (pt) 2010-11-17 2016-08-02 Asuragen Inc mirnas como biomarcadores para distinguir neoplasmas de tireoide benignos de malignos
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
EP2681566A2 (en) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2013063519A1 (en) 2011-10-26 2013-05-02 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
WO2013063544A1 (en) 2011-10-27 2013-05-02 Asuragen, Inc. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
WO2014007623A1 (en) 2012-07-03 2014-01-09 Interna Technologies B.V. Diagnostic portfolio and its uses
WO2014055117A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
CA2907377A1 (en) 2013-03-15 2014-09-18 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US9944992B2 (en) 2013-03-15 2018-04-17 The University Of Chicago Methods and compositions related to T-cell activity
US9835587B2 (en) 2014-04-01 2017-12-05 C.C. Imex Electrophoresis running tank assembly
CN111566212A (zh) 2017-11-03 2020-08-21 因特尔纳技术有限公司 miRNA分子,等同物,安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
WO2019104155A2 (en) 2017-11-22 2019-05-31 The University Of Chicago Chemical probe-dependent evaluation of protein activity and uses thereof
CN112218708B (zh) * 2018-05-15 2023-06-16 生物复制有限公司 微阵列变换器
EP3947727A4 (en) 2019-04-05 2023-01-04 Board of Regents, The University of Texas System METHODS AND APPLICATIONS OF CELL BARCODING
JP7566775B2 (ja) 2019-04-12 2024-10-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 筋肉量及び酸化的代謝を増加させるための組成物及び方法
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders
WO2025248505A1 (en) 2024-05-31 2025-12-04 Wayne State University Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002582A (en) * 1982-09-29 1991-03-26 Bio-Metric Systems, Inc. Preparation of polymeric surfaces via covalently attaching polymers
GB8314523D0 (en) * 1983-05-25 1983-06-29 Lowe C R Diagnostic device
US6589726B1 (en) * 1991-09-04 2003-07-08 Metrigen, Inc. Method and apparatus for in situ synthesis on a solid support
CA2124087C (en) * 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
US5795714A (en) * 1992-11-06 1998-08-18 Trustees Of Boston University Method for replicating an array of nucleic acid probes
RU2041261C1 (ru) * 1993-08-11 1995-08-09 Институт молекулярной биологии им.В.А.Энгельгардта РАН Способ изготовления матрицы для детектирования мисматчей
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6147205A (en) * 1995-12-15 2000-11-14 Affymetrix, Inc. Photocleavable protecting groups and methods for their use
US6057100A (en) * 1996-06-07 2000-05-02 Eos Biotechnology, Inc. Oligonucleotide arrays
US6406845B1 (en) * 1997-05-05 2002-06-18 Trustees Of Tuft College Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample
US6121027A (en) * 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
WO2000036398A2 (de) * 1998-12-14 2000-06-22 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Verfahren und vorrichtungen zur erfassung optischer eigenschaften, insbesondere von lumineszenz-reaktionen und brechungsverhalten, von auf einem träger direkt oder indirekt gebundenen molekülen
AU2001288960A1 (en) * 2000-09-27 2002-04-08 Surmodics, Inc. High density arrays

Similar Documents

Publication Publication Date Title
JP2005537480A5 (ja)
Ramazani et al. The reaction of (N‐isocyanimino) triphenylphosphorane with an electron‐poor α‐haloketone in the presence of aromatic carboxylic acids: A novel three‐component reaction for the synthesis of disubstituted 1, 3, 4‐oxadiazole derivatives
US4327222A (en) 3,4-Diarylisoxazol-5-acetic acids and process for making same
JP2005501841A5 (ja)
JP2007326874A (ja) 置換インダノンの製造方法
TW201139400A (en) Process for the synthesis of ketobenzofuran derivatives
Sayed et al. Conversion of 3‐arylazo‐5‐phenyl‐2 (3H)‐furanones into other heterocycles of anticipated biological activity
Chao et al. Silver (I)-mediated three-component annulation reaction of [60] fullerene, sulfonylhydrazones, and nitriles: leading to diverse disubstituted [60] fullerene-fused dihydropyrroles
Katritzky et al. The chemistry of benzotriazole. 10. A conceptually new approach to the synthesis of secondary amides and thioamides
JPH07188069A (ja) アルキルシクロペンタジエン類の製造
DE69803652T2 (de) Verfahren zur herstellung von cyclopentadienylverbindungen
Schantl et al. Addition products of hydrazine derivatives to azo-alkenes-III. α-phenylhydrazino-phenylhydrazones
CN103570584B (zh) 一种取代苯甲脒类化合物的合成方法
Choudhary et al. Preparation and properties of N-Methyl-and N-(4-Chlorophenyl)-substituted hydroxamic acids
CN113861169A (zh) 多取代萘并二氢呋喃类化合物、及其制备方法、及其用途
Pal et al. Novel naproxen derivatives: lewis acid/transition-metal free synthesis via CC bond forming reaction
Liu et al. A general and efficient method for synthesis of enaminones and enamino esters catalyzed by NbCl5 under solvent-free conditions
Klepo et al. Studies in the furan series. 22. N-Arylfurfuryl-and 5-methylfurfurylamines and their N-allyl derivatives
EP0496884A1 (en) Pyrrole monomer, process for preparing the same, and functional polymer film
JPH0686425B2 (ja) 新規ビスマレイミド化合物およびその製造方法
JP3265135B2 (ja) 側鎖にウレイド基を有するチオフェン単量体および重合体
JP2696109B2 (ja) 新規ジアミン誘導体
CN102675185A (zh) 一种间二芳基甲酰肼化合物及其制备方法、用途
JP2005187413A (ja) 新規な相転移型スピンクロスオーバートリアゾール鉄錯体
CN109096324B (zh) 一种二烷基酰基氯化锗合成方法与应用